Search results

Back

COMMON QUESTIONS

90% of our funding comes from individual donors. Learn how you can support MSF’s lifesaving care with a gift.

DONATE Menu
Scroll down for content

News & stories

Get the latest news, stories, videos, and more from our medical humanitarian projects around the world.

Mother sits beside her child receiving treatment for malaria.

Climate change is worsening the malaria epidemic in Madagascar

story Apr 24, 2024

News Apr 23, 2024

As Danaher reports earnings, MSF repeats call for $5 GeneXpert tests

Protesters holding signs in Washington, DC as part of the Time for $5 campaign.

story Apr 25, 2024

How inequitable access to quality health care drives antimicrobial resistance

Patients in their hospital beds at MSF's Aden Trauma Hospital in Yemen.

story Apr 23, 2024

Emotional support for health workers on Ukraine's front lines

MSF psychologist Vika hugs Antonina Sakhnovska, an MSF mental health patient in Kharkiv, when she begins to cry when she remembers her husband, who died in the war.

story Apr 23, 2024

Everything you need to know about cholera

A health care worker wearing PPE in MSF's Cholera Treatment Center in Quelimane, Mozambique.

Speaking out about the emergencies our staff and patients witness is part of who we are. Explore our history and principles.

News & stories

190 results

News | Apr 25, 2024

MSF publishes cost of its TB clinical trial

Transparency on clinical trial costs must become the norm to improve access to medical products worldwide.

Read More
An older patient sits with her grandson at one of MSF's active case-finding sites for tuberculosis.

News | Apr 23, 2024

As Danaher reports earnings, MSF repeats call for $5 GeneXpert tests

Medical testing shouldn't be a luxury. Danaher and Cepheid must drop the price of GeneXpert for low- and middle-income countries

Read More
Protesters holding signs in Washington, DC as part of the Time for $5 campaign.

News | Mar 19, 2024

Help us stop the profiteering on medical tests

Sign the petition to demand drug manufacturers Cepheid and Danaher drop the price of GeneXpert tests for low- and middle-income countries.

Read More
Time for $5

News | Feb 23, 2024

Ukraine crisis response

How MSF continues to provide care to people impacted by fighting and displacement, two years since the escalation of the conflict in Ukraine.

Read More
MSF psychologist and children walk outside in Ukraine.

News | Sep 30, 2023

MSF welcomes J&J's decision to not enforce unnecessary patents on key TB drug

The decision makes a lifesaving TB drug more accessible to people in low- and middle-income countries.

Read More
Protesters hold signs in front of Wall Street as part of MSF's access campaign for TB drug bedaquiline

News | Sep 22, 2023

UN commitments to scale up TB testing and treatment require immediate action

World leaders committed to ramp up TB testing, treatment, and prevention efforts—for both adults and children.

Read More
A child sits between two people in surgical masks after completing TB treatment from MSF in Papua New Guinea.

News | Sep 19, 2023

MSF: TB test price reduction is a step in the right direction

Cepheid and its parent company Danaher announced today that they are reducing the price of the Xpert MTB/RIF test for TB by 20 percent in high-TB-burden countries.

Read More
An MSF team surrounded by patients is working around a table surrounded by tuberculosis medication in Tondo, Manila.

News | Sep 12, 2023

J&J and Cepheid must expand access to TB drug and tests

TB is curable but remains the world’s leading infectious disease killer as pharma corporations stand in the way of affordable medical tools

Read More
A patient sits at a table in front of an MSF staff member for a free X-ray at an MSF tuberculosis (TB) screening sites in Manila.

News | Aug 24, 2023

MSF closes medical operations in Tripoli, Libya

Tripoli has become an increasingly challenging environment for international organizations.

Read More
MSF staff members wearing face masks, headscarves, and white vests speak to a man with back turned in Libya.

News | Jul 18, 2023

J&J must withdraw extended patents on lifesaving TB drug

Recent deal offering controlled generics access in limited countries does not go far enough

Read More
A patient sits at a table in front of an MSF staff member for a free X-ray at an MSF tuberculosis (TB) screening sites in Manila.

Filters

Clear all
Country
Focus issues
Medical issues
Content type
Date range
For Donation Inquiries 
See donor options here. 
 
U.S. Media Inquiries 
Reach out to the press team. 
 
Non-U.S. Media Inquiries 
Contact the MSF office in your country/territory.
For Donation Inquiries 
See donor options here. 
 
U.S. Media Inquiries 
Reach out to the press team. 
 
Non-U.S. Media Inquiries 
Contact the MSF office in your country/territory.

Support our work where it’s needed most.

Your unrestricted gifts enable us to provide lifesaving medical humanitarian care on the ground and speak out about what we see.

Donate

© Médecins Sans Frontières 2024 Federal tax ID#: 13-3433452

© Médecins Sans Frontières 2024 Federal tax ID#: 13-3433452

How we use funds

Your gift helps us provide medical humanitarian aid for hundreds of thousands of people each year.

Learn more

83%

Programs

16%

Fundraising

1%

Management & General Admin

MSF